CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MedRisk LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MedRisk LLC
2701 Renaissance Boulevard
Phone: 800.225.9675p:800.225.9675 King of Prussia, PA  19406  United States

This is a Subsidiary, click here for the Parent Company

Business Summary
MedRisk LLC is a debt issuer formed by TA Associates, a Boston–based private-equity firm, to facilitate its acquisition of a significant minority stake in MedRisk, Inc. (the "Company"). The Company is a provider of managed physical medicine and diagnostic imaging services for the workers’ compensation industry and related market sectors. Customers include insurance carriers, self-insured employers, third-party administrators, state funds, and case management companies. MedRisk LLC is an intermediate subsidiary of MedRisk MidCo LLC.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
----Yes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes----


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 12, 2024